Camptosar Injection (Irinotecan Hydrochloride) Drug Information: Overdosage and Contraindications

Pill Identifier Search

May 25, 2012

Camptosar Inj

Colon Cancer »

Colon cancer facts

Colorectal cancer is a malignant tumor arising from the inner wall of the large intestine.
Colorectal cancer is the third leading cause of cancer in males and fourth in females in the U.S.
Risk factors for colorectal cancer include heredity, colon polyps, and long-standing ulcerative colitis.
Most colorectal cancers develop from polyps. Removal of colon polyps can prevent colorectal cancer.
Colon polyps and early cancer can have no symptoms. Therefore regular screening is important.
Diagnosis of colorectal cancer can be made by barium enema or by colonoscopy with biopsy confirmation of cancer tissue.
Treatment of colorectal cancer depends on the location, size, and extent of cancer spread, as well as the age and health of the patient.
Surgery is the most c...

Read the Colon Cancer article »

« Previous
1
2
3
4
5
6
7
8
9
10
11
12
13
Next »

Camptosar Injection User Reviews >>

Camptosar Injection

Breast Cancer Slideshow Pictures

Pancreatic Cancer Slideshow Pictures

Skin Cancer Slideshow Pictures

font size

OVERDOSE

In U.S. phase 1 trials, single doses of up to 345 mg/m² of irinotecan were administered to patients with various cancers. Single doses of up to 750 mg/m² of irinotecan have been given in non-U.S. trials. The adverse events in these patients were similar to those reported with the recommended dosage and regimen. There have been reports of overdosage at doses up to approximately twice the recommended therapeutic dose, which may be fatal. The most significant adverse reactions reported were severe neutropenia and severe diarrhea. There is no known antidote for overdosage of CAMPTOSAR. Maximum supportive care should be instituted to prevent dehydration due to diarrhea and to treat any infectious complications.